Moderna Cancer Treatment Shows Promise in Clinical Trial

Why it matters locally: While the treatment is still in clinical trials, the development of new cancer therapies could eventually offer new options for patients being treated at medical facilities across Arizona.

Moderna's shares increased after the company announced positive results for its experimental mRNA-based cancer treatment. The therapy, called intismeran, is under development in collaboration with Merck. Researchers designed intismeran to be customized for individual patients. It targets specific mutations found within each patient's tumor.